Recombinant multi-species NDUFC2-KCTD14 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NDUFC2-KCTD14 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This locus represents naturally occurring read-through transcription between the neighboring NDUFC2 (NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa) and KCTD14 (potassium channel tetramerisation domain containing 14) genes on chromosome 11. The read-through transcripts share sequence identity with the upstream gene product and one variant has a frameshifted C-terminal region derived from the downstream gene exons. [provided by RefSeq, Feb 2011]
The Alternative Names of target: NADH dehydrogenase [ubiquinone] 1 subunit C2,NDUFC2-KCTD14,NDUFC2-KCTD14 readthrough transcript protein,isoform 2

Target products collectionGo to NDUFC2-KCTD14 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP1263-Ag-1/ GM-Tg-hg-IP1263-Ag-2 Human NDUFC2-KCTD14 protein Human
GM-Tg-rg-IP1263-Ag-1/ GM-Tg-rg-IP1263-Ag-2 Rat NDUFC2-KCTD14 protein Rat
GM-Tg-mg-IP1263-Ag-1/ GM-Tg-mg-IP1263-Ag-2 Mouse NDUFC2-KCTD14 protein Mouse
GM-Tg-cynog-IP1263-Ag-1/ GM-Tg-cynog-IP1263-Ag-2 Cynomolgus/Rhesus macaque NDUFC2-KCTD14 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP1263-Ag-1/ GM-Tg-felg-IP1263-Ag-2 Feline NDUFC2-KCTD14 protein Feline
GM-Tg-cang-IP1263-Ag-1/ GM-Tg-cang-IP1263-Ag-2 Canine NDUFC2-KCTD14 protein Canine
GM-Tg-bovg-IP1263-Ag-1/ GM-Tg-bovg-IP1263-Ag-2 Bovine NDUFC2-KCTD14 protein Bovine
GM-Tg-equg-IP1263-Ag-1/ GM-Tg-equg-IP1263-Ag-2 Equine NDUFC2-KCTD14 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP1263-Ag-1/ GM-Tg-hg-IP1263-Ag-2; GM-Tg-rg-IP1263-Ag-1/ GM-Tg-rg-IP1263-Ag-2;
GM-Tg-mg-IP1263-Ag-1/ GM-Tg-mg-IP1263-Ag-2; GM-Tg-cynog-IP1263-Ag-1/ GM-Tg-cynog-IP1263-Ag-2;
GM-Tg-felg-IP1263-Ag-1/ GM-Tg-felg-IP1263-Ag-2; GM-Tg-cang-IP1263-Ag-1/ GM-Tg-cang-IP1263-Ag-2;
GM-Tg-bovg-IP1263-Ag-1/ GM-Tg-bovg-IP1263-Ag-2; GM-Tg-equg-IP1263-Ag-1/ GM-Tg-equg-IP1263-Ag-2
Products Name NDUFC2-KCTD14 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name NDUFC2-KCTD14
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NDUFC2-KCTD14 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.